The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic ...

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first skin cream for adults with long-term or chronic hand eczema (CHE), which ...

Adult patients with moderate to severe hand eczema with previous treatment failure or in whom topical corticosteroids are ...

The first therapy specifically indicated for chronic hand eczema (CHE) has passed muster at the FDA.

The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...

Danish dermatology specialist Leo Pharma has scored an FDA approval that makes its JAK inhibitor cream Anzupgo (del | Despite chronic hand eczema affecting 1 in 10 people worldwide, there was no ...

These seven baby lotions keep babies’ skin soft and help them stay cool, calm, and comfortable all day long without causing ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

By the time he was 17 years old, Reuben Loo claimed to have accumulated seven figures by investing into crypto. Not only that ...

LEO launches chronic hand eczema drug in its first market Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE).